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A series of twenty one substituted pyrazolo[3,4-d]pyrimidines-4-amines were studied by 1H and 13C 
NMR. The application of two-dimensional techniques, HMQC and HMBC, allowed the complete 
assignment of the spectra for all the compounds. 
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 Figure 1. Structures and numbering for compounds 
 
INTRODUCTION 
As part of our ongoing research program on heterocyclic compounds which may serve 
as leads for designing novel chemotherapeutic agents, we have been involved on the 
preparation of pyrazolopyrimidines [1, 2]. These compounds and other related fused 
heterocycles are known to exhibit biological activity of several types such as CNS 
depressant [3], neuroleptic [4], tuberculostatic [5], antibacterial and antifungal [2, 6]. It 
was also reported that pyrazolo[3,4-d]pyrimidines inhibit xanthine oxidase [7, 1].  
 
RESULTS AND DISCUSSION 






























































































The compounds described (Figure 1) constitute a series of pyrazolo[3,4-d]pyrimidines 
containing in position 1 a p-substituted phenyl group and in position 6 a heterocyclic  or 
aryl ring.  
The 1H NMR signals of the aryl substituent on position 1, the proton 3 and NH2 
were readily attributed.   
The assignment of the remaining protons and the 13C signals was achieved by 
concerted application of proton-detected (C,H) 1-bond (HMQC) and long range 
(HMBC) heteronuclear two-dimensional chemical shift correlation experiments.  
The proton and carbon chemical shifts assignments are presented in tables 1 and 2.  
 
EXPERIMENTAL 
1H NMR spectra were recorded at 300 MHz and 13C NMR spectra at 75.4 MHz both on 
a Varian Unity Plus Spectrometer. The spectra were obtained at 298 K, in 5 mm tubes, 
using DMSO-d6 or acetone- d6, with the solvent (residual) peak as internal reference: 
DMSO-d6: δ 2.49 (1H) and δ 39.5 (13C); acetone- d6: δ 2.05 (1H) and δ 29.9 (13C). 
1H NMR parameters were as follows: spectral width, 4000 Hz; data points, 32 K; 
pulse width 45º, acquisition time 2.8 s. 13C NMR parameters were as follows: spectral 
width, 18850; data points, 64K; pulse width 45º, acquisition time 1.8 s; delay 1 s.  
Heteronuclear 1H-13C HMQC and HMBC experiments were carried out using 
standard procedures. The spectra widths were F1 = 18100 Hz and F2 = 5000 Hz. The 
spectra were collected as 2048 x 256 block data and processed using a sinusoidal 
multiplication in each dimension.  HMQC was optimized for 1J (13C, 1H = 140 Hz) and 
HMBC for long-range 13C, 1H coupling constants of 8 Hz.  
 
Materials 
The pyrazolo[3,4-d]pyrimidine derivatives used in this study were prepared in our 
laboratory [2].  
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Table 1. 1H chemical shiftsa (multiplicities, coupling constants in Hertz) of pyrazolopyrimidines   
 H3 NH2 H-2’ H6’ H3’ H5’ H4’ H2” H6” H3” H5” H4” 
















          














7.18(tt, 6.9, 1.2) 
           
1c 8.38 (s) 8.14(vbrs) 8.26(dd, 8.7, 1.2) 7.59(t, 8.0) 7.36(tt, 7.5,1.2) 8.66-8.73 (m) 7.96(dt, 7.5, 1.5) - 7.73(t, 8.8) 8.66-8.73 (m) 
2c 8.39 (s) 8.20;8.00(2 brs) 8.32(dd, 7.2, 2.1) 7.65(dd, 6.9, 2.1) - 8.66-8.64 (m) 7.95(dt, 7.8, 1.5) - 7.73(t, 7.8) 8.66-8.64 (m) 
3c 8.38 (s) 8.18(vbrs) 8.26(d, 8.7) 7.76(d, 8.7) - 8.72-8.66 (m) 7.95(dt, 7.5, 1.2) - 7.71(t, 8.1) 8.72-8.66 (m) 
 
          
1d 8.39 (s) 8.16;7.96(2 brs) 8.30(dd, 8.7, 1.2) 7.52-7.64(m) 7.52-7.64(m) 9.54(d, 2.1) 8.67-8.64 (m) - 7.36(t, 7.5) 8.67-8.64 (m) 
2d 8.39 (s) 8.16;8.00(2 brs) 8.36(d, 9.0) 7.65(d, 9.0) - 9.50(brs) 8.73-8.65 (m) - 7.58-7.50 (m) 8.73-8.65 (m) 
3d 8.41 (s) 8.17 (brs) 8.31(d, 9.0) 7.79(d, 9.0) - 9.56(d, 2.1) 8.68(d, 7.0) - 7.58-7.52 (m) 8.68(d, 7.0) 
 
          















         
  
1f 8.33 (s) 7.93(vbrs) 8.30(dd, 7.5, 1.5) 7.57(t, 7.5) 7.34(t, 7.5) - - 7.93 (dd, 3.6, 1.2) 7.69(dd, 5.3, 1.5) 7.18(dd, 5.0, 3.9) 
a
 In ppm from  the solvent peak *CH2 4.01; 4.01; 4.02 (for compounds 1b, 2b, 3b, respectively); **Acetone-d6.  Vbrs-very broad singlet 
 
 
Table 2. 13C chemical shifts of pyrazolopyrimidines 
 
2f 8.34 (s) 7.97(vbrs) 8.33(d, 9.0) 7.62(d, 9.3) - - - 7.94(dd, 3.9, 1.2) 7.70(dd, 5.1, 1.2) 7.18(dd, 5.1, 3.9) 
3f** 8.34 (s) 7.37(brs) 8.47(d, 9.0) 7.78(d, 9.0) - - - 8.06(dd, 3.9, 1.2) 7.65(dd, 5.1, 1.2) 7.20(dd, 5.1, 3.9) 
 
          
1g 8.78 (s) 7.87(brs) 8.92(d, 7.8) 8.03(t, 8.0) 8.40-7.76(m) - - 8.40-7.76 (m) 8.25-8.20 (m) 7.10(dd, 3.6, 1.5) 
2g 8.35 (s) 8.00(brs) 8.53(d, 9.3) 7.62(d, 9.3) - - - 7.34(dd, 3.3, 0.9) 7.90-7.70 (m) 6.66(dd, 3.3, 1.8) 
3g 8.35 (s) 8.00(vbrs) 8.28(d, 9.3) 7.75(d, 9.0) - - - 7.26(dd, 3.3, 0.9) 7.90-7.87 (m) 6.67(dd, 3.3, 1.5) 
Compound C-2’ 
C6’ 
C3’ C5’ C4’ C1’ C3 C3a C4 C6 C7a C1” C2” C6” C3” C5” C4” 
1a 120.5 129.3 126.0 139.3 134.3 100.4 158.3 162.0 154.6 138.0 128.2 128.2 128.4 128.4 130.5 
2a 121.8 129.2 130.5 137.8 134.6 100.3 158.2 162.0 154.7 138.0 128.1 128.1 128.3 128.3 129.9 
3a 122.2 132.2 118.3 137.9 134.7 100.4 158.3 162.1 154.8 138.5 128.4 128.4 128.2 128.2 130.6 
 
               
1b* 120.4 129.2 126.2 or  4” 139.2 134.1 99.8 158.4 167.7 154.4 139.0 129.1  129.1 128.3 128.3 126.0 or 4’) 
2b* 121.6 129.1 129.8 138.0 134.4 99.8 158.3 167.8 154.4 138.8 129.0 129.0 128.2 128.2 126.2 
3b* 121.9 132.0 118.0 138.5 134.5 99.8 158.3 167.8 154.5 138.8 129.0 129.0 128.2 128.2 126.2 
                
1c** 120.7 129.4 126.2 139.0 134.3 100.7 158.4 159.8 154.2 111.6 131.5 133.8 139.2 129.9 132.6 
2c** 122.0 129.3 130.1 137.8 134.6 100.7 158.3 159.9 154.3 111.6 131.4 133.8 139.0 129.8 132.6 
3c** 122.4 132.2 118.8 138.3 134.7 100.7 158.3 159.9 154.3 111.6 131.5 133.9 139.0 129.9 132.6 
 
               
1d 120.6 129.3 126.2 139.1 134.3 100.6 158.4 160.2 154.2 -- 151.1 135.4 133.4 123.6 149.4 
2d 122.0 129.3 130.1 137.9 134.7 100.6 158.4 160.4 154.4 -- 149.4 135.5 133.3 123.6 151.1  
3d 122.2 132.2 118.3 138.3 135.4 100.6 158.3 160.3 154.3 -- 151.1 134.7 133.2 123.6 149.4 
 
               
1e 120.6 129.3 126.2 139.0 134.3 100.9 158.4 159.9 154.1 -- 150.2 150.2 122.0      122.0 145.2 
2e 122.0 129.3 130.2 137.8 134.7 101.0 158.4 160.0 157.4 -- 150.2 150.2 122.0 122.0 145.1 
3e 122.3 132.2 118.4 138.2 134.7 101.0 158.4 160.0 154.3 -- 150.2 150.2 122.0 122.0 145.1 
              
  
1f 120.2 129.2 125.9 139.2 134.3 100.1 158.1 158.6 154.0 -- 144.0 -- 128.5 130.1 128.2 
a
 In ppm from the solvent peak *CH2 45.5; 45.4; 45.4 (for compounds 1b, 2b, 3b, respectively);   ** CN 118.8; 118.7; 118.4 (for compounds 1c, 2c, 3c, respectively)    ***Acetone-d6 
2f 121.8 129.4 128.4 138.1 134.8 100.3 158.3 158.9 154.3 -- 143.9 -- 130.4 128.8 130.1 
3f*** 122.9 132.8 119.1 139.9 134.8 101.3 159.3 160.1 155.6 -- 145.2 -- 130.5 128.7 129.6 
 
               
1g 121.3 129.7 126.6 140.7 134.2 101.3 156.4 159.4 155.5 -- 154.1 -- 113.8 145.5 112.7 
2g 122.6 129.8 131.3 139.5 134.7 101.3 156.6 159.4 154.0 -- 145.6 -- 114.0 141.8 112.7 
3g 122.0 132.1 118.2 138.4 134.7 100.2 155.3 158.2 154.2 -- 152.4 -- 113.2 145.2 112.2 
